Pilpeline &
Show cases
We are generating
the next pharmaceutical using our pipeline
HER2
Experimental Kd
2.1 nM
Design the Lead
Completed · Q1 2026
Optimize the Lead
Completed · Q1 2026
In Vitro Binding Assay
Completed · Q1 2026
In Vivo Validation
In Progress · Q2 2026
Translational & Regulatory Step
Upcoming · Q3 2026
Clinical Trial
Upcoming · Q4 2026
CD38
Experimental Kd
19.5 nM
Design the Lead
Completed · Q1 2026
Optimize the Lead
Completed · Q1 2026
In Vitro Binding Assay
Completed · Q1 2026
In Vivo Validation
In Progress · Q2 2026
Translational & Regulatory Step
Upcoming · Q3 2026
Clinical Trial
Upcoming · Q4 2026
PD-L1
Experimental Kd
45 nM
Design the Lead
Completed · Q1 2026
Optimize the Lead
Completed · Q1 2026
In Vitro Binding Assay
Completed · Q1 2026
In Vivo Validation
In Progress · Q2 2026
Translational & Regulatory Step
Upcoming · Q3 2026
Clinical Trial
Upcoming · Q4 2026
TROP2
Experimental Kd
8.5 nM
Design the Lead
Completed · Q1 2026
Optimize the Lead
Completed · Q1 2026
In Vitro Binding Assay
Completed · Q1 2026
In Vivo Validation
In Progress · Q2 2026
Translational & Regulatory Step
Upcoming · Q3 2026
Clinical Trial
Upcoming · Q4 2026
Accelerating Toward the Clinic
Our lead AI-designed candidates are now being tested in vivo.
We are advancing our top programs toward clinical trials.
Coming Soon…